GlaxoSmithKline, the UK-listed drugmaker, has designated Singapore as its Asia headquarters and will shift some of its US and UK staff to the city-state, in an effort to tap growing demand in the region.
The move comes as GSK handles the fallout from having been found guilty by a Chinese court in September of bribing doctors in China to prescribe its medicines.
It emerged this month that GSK had dismissed more than 100 staff in China following its internal investigation into the corruption scandal for which it was fined £300m last year.
您已閱讀25%（540字），剩餘75%（1593字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。